HYRIS is a platform that developed the smallest DNA analyzer available in the market for niche portable application. The company develops and markets a disruptive platform for mobile DNA analysis, including all hardware and software elements needed. It is already in the market with commercial sales to several top tier industrial and governmental clients in Europe and North America. A new alliance was recently announced for the deployment of its technology in the botanical field for pharmaceutical and cosmetics.
Cross Border assisted Hyris to find partners funding a capital increase for the company’s growth.
Cross Border assisted in the preparation of the business plan and selection of Seed Capital Investors.
Cross Border advised the management in structuring the shareholders agreement and stock options structure.